Vivaldi Capital Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $364K | Buy |
|
|||||
|
2025
Q1 | $67.9K | Buy |
|
|||||
|
2024
Q4 | $55.7K | Buy |
|
|||||
|
2024
Q3 | $66.1K | Hold |
|
|||||
|
2024
Q2 | $54.3K | Hold |
|
|||||
|
2024
Q1 | $72.8K | Buy |
|
|||||
|
2023
Q4 | $32.6K | Hold |
|
|||||
|
2023
Q3 | $37K | Hold |
|
|||||
|
2023
Q2 | $27.7K | Hold |
|
|||||
|
2023
Q1 | $40.4K | Hold |
|
|||||
|
2022
Q4 | $22.5K | Hold |
|
|||||
|
2022
Q3 | $30K | Buy |
|
|||||
|
2022
Q2 | $22K | Hold |
|
|||||
|
2022
Q1 | $23K | Buy |
|
|||||
|
2021
Q4 | $22K | Hold |
|
|||||
|
2021
Q3 | $41K | Hold |
|
|||||
|
2021
Q2 | $36K | Hold |
|
|||||
|
2021
Q1 | $45K | Sell |
|
|||||
|
2020
Q4 | $35K | Hold |
|
|||||
|
2020
Q3 | $42K | Hold |
|
|||||
|
2020
Q2 | $40K | Buy |
|
|||||
|
2020
Q1 | $21K | Hold |
|
|||||
|
2019
Q4 | $31K | Hold |
|
|||||
|
2019
Q3 | $39K | Hold |
|
|||||
|
2019
Q2 | $44K | Buy |
|